Serum erythropoietin levels in children with thalassemia and iron deficiency anemia

Basit Öğe Kaydı
dc.contributor.authorGüngör Nişli
dc.contributor.authorKaan Kavaklı
dc.contributor.authorZafer Kurugöl
dc.contributor.authorYeşim Aydınok
dc.contributor.authorSenay Öztop
dc.contributor.authorNazan Çetingül
dc.contributor.authorHayal Özkılıç
dc.date.accessioned2019-10-26T20:07:22Z
dc.date.available2019-10-26T20:07:22Z
dc.date.issued1996
dc.departmentEge Üniversitesien_US
dc.description.abstractErythropoietin (EPO) levels were determined in sera from children with different types of anemia using radioimmunoassay (IRMA). Our aim was to evaluate EPO levels in various types of anemia and analyze the possible relationship between EPO levels and hematological parameters. Seventy-two patients with anemia (33 ferpale, 39 male), between 2 and 44 years of age were studied. Mean serum EPO levels were found to be 324.2 ± 71.5 mlll/mL in thalassemia major (n=44), 117+59 mlU/mL in thalassemia intermedia (n=11), 24.1 ±4.8 mlU/mL in iron deficiency anemia (n=17) and 9.4+0.7 mlU/mL in healthy controls (n=39). EPO levels did not differ in relation to age, sex, ferritin levels, splenectomy and chelation therapy for thalassemia group. EPO levels were significantly higher in thalassemia major group than all others (p<0.05). A significant inverse relationship was not found between Hb and EPO levels or logarithmic values of EPO. The data presented demonstrates that EPO levels in anemic patients are not only inversely related to the Hb values, but also to the proliferative activity of bone morrow.en_US
dc.description.abstractErythropoietin (EPO) levels were determined in sera from children with different types of anemia using radioimmunoassay (IRMA). Our aim was to evaluate EPO levels in various types of anemia and analyze the possible relationship between EPO levels and hematological parameters. Seventy-two patients with anemia (33 ferpale, 39 male), between 2 and 44 years of age were studied. Mean serum EPO levels were found to be 324.2 ± 71.5 mlll/mL in thalassemia major (n=44), 117+59 mlU/mL in thalassemia intermedia (n=11), 24.1 ±4.8 mlU/mL in iron deficiency anemia (n=17) and 9.4+0.7 mlU/mL in healthy controls (n=39). EPO levels did not differ in relation to age, sex, ferritin levels, splenectomy and chelation therapy for thalassemia group. EPO levels were significantly higher in thalassemia major group than all others (p<0.05). A significant inverse relationship was not found between Hb and EPO levels or logarithmic values of EPO. The data presented demonstrates that EPO levels in anemic patients are not only inversely related to the Hb values, but also to the proliferative activity of bone morrow.en_US
dc.identifier.endpage72en_US
dc.identifier.issn1300-7777
dc.identifier.issue2en_US
dc.identifier.startpage69en_US
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TkRFMk9UYzM=
dc.identifier.urihttps://hdl.handle.net/11454/15549
dc.identifier.volume14en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofTurkish Journal of Hematologyen_US
dc.relation.publicationcategoryDiğeren_US]
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHematolojien_US
dc.titleSerum erythropoietin levels in children with thalassemia and iron deficiency anemiaen_US
dc.typeOtheren_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu